FN is a marker for EMT-driven cancer stemness and induces EMT; increases the adhesion, proliferation and chemoresistance of glioma stem cells as well as their capacity for differentiation through the integrin/FAK/paxillin/AKT signaling pathway. Here, AKT1 is linked to central nervous system cancer.